NCT04283669 2026-03-13
NF110
University of Alabama at Birmingham
Phase 2 Completed
Clinical Trials
3 trialsNCT07420751 2026-02-20
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
Massachusetts General Hospital
Phase NA Recruiting
NCT07131722 2026-01-23
Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
PRG Science & Technology Co., Ltd.
Phase 1/2 Not yet recruiting